This Stock Could Explode 💥

Good Morning! Hey, there! It's Chris from Elite Trade Club, here to give you this morning's premarket trading news. Today is Wednesday, August 23rd. I hope you have a great trading session. Now, let's get ready to trade! Markets 📈 U.S. indexes edged lower on Tuesday. The Dow lost a half-point, while the S&P 500 and Russell 2K fell 0.2%. The Nasdaq closed with a small gain of less than 0.1%. Today, futures are edging higher in early trading. S&P 500 contracts are up 0.1%. Sponsored [This Stock Could Explode 💥]( After a series of major breakthroughs, we're watching this promising growth stock very closely... The company recently partnered with Deepak Chopra and got several other heavy hitters to join its board of directors. Better yet, its main business is already generating real revenues, and it recently secured a $150 million credit line that could fuel further expansion. It's no wonder the "Smart Money" is taking notice, with two notable billionaire family offices have just made big investments in the company. This up-and-coming growth stock checks all the boxes for potential success, and now could be a great time to make a move. [Get all the Details Here [Ticker Included]]( Premarket Highlights 🔎 ⚪ None. So far, it's a relatively quiet premarket with no major news to report. What to Watch Today 👀 NVIDIA Earnings Today's most anticipated event is Nvidia's quarterly earnings report. The company has become Wall Street's favorite AI stock over the past few months, but will NVIDIA's growing AI business supply the revenue growth investors expect? We'll find out today, after the closing bell, when NVDA drops its latest earnings report, so stay tuned after the market closes. The after-market report could set the tone for tomorrow's premarket as well. Major Earnings 💰 Analog Devices, Inc. [ADI] ... AM Grab Holdings Limited [GRAB] ... AM Bath & Body Works, Inc. [BBWI] ... AM Williams-Sonoma, Inc. [WSM] ... AM Full Truck Alliance Co. Ltd. Dr [YMM] ... AM Nvidia Corporation [NVDA] ... PM Snowflake Inc. [SNOW] ... PM Autodesk, Inc. [ADSK] ... PM Splunk Inc. [SPLK] ... PM Netapp, Inc. [NTAP] ... PM Economy 🏗 - S&P flash U.S. services PMI [Aug] ... 9:45a - S&P flash U.S. manufacturing PMI [Aug] ... 9:45a - New home sales [Jul] ... 10:00a Running Hot 🔥 Gainers - BioNexus Gene Lab [BGLC] >> +29.7% - CF Acquisiton [CFFEU] >> +30.7% - Rail Vision Unit [RVSN] >> +25.0% - LAMF Global Ventures [LGVC] >> +21.1% Decliners - Foot Locker [FL] >> (30.6%) - Peloton Interactive [PTON] >> (28.4%) - VinFast Auto [VFS] >> (15.6%) - AMC Entertainment [AMC] >> (19.2%) Arcus Biosciences [RCUS] - Last Close: $18.81 Arcus Biosciences is getting a boost in today's premarket. The biotech stock is gaining after Swiss rival Roche [RHHBY] inadvertently published positive interim data from trials of its lung cancer drug. Roche Group subsidiary Genentech shared data from a Phase III SKYSCRAPER-01 study evaluating tiragolumab plus Tecentriq®. The clinical update provoked an uptick in Arcus Bio, who is developing a similar treatment. RCUS is up 34.5% in the premarket. My Take: It was hard to pin down the catalyst for this rally, but this looks like it. RCUS could see gains if its drug performs similarly. Apellis Pharma [APLS] - Last Close: $30.76 An upbeat clinical update is rallying shares of Apelis Pharma. The pharma firm said an ongoing review of syfovre showed no signs of an increased risk of retinal vasculitis associated with an increased risk of vision loss. Apellis said phase 3 investigators confirmed there were zero instances of retinal vasculitis observed during the trial. "As part of our ongoing review, we have seen no indication that drug product or manufacturing issues contributed to these events," said CEO Cedric Francois. APLS is up 25.9% in response to the clinical update. My Take: APLS seems to have convinced the market that this treatment is mostly safe, but it still has a steep hill to climb before it gets back to its 52-week highs. Iteos Therapeutics [ITOS] - Last Close: $11.75 A rebound rally is boosting shares of Iteos Therapeutics. The micro-cap biotech stock set a new 52-week low yesterday after an analyst downgrade earlier this week. However, shares are rebounding dramatically in today's premarket trading session. ITOS is up 37.0% in early premarket trading. My Take: ITOS may have bottomed out, but I want to see more progress before I'm sold. Heliogen [HLGN] - Last Close: $0.211 Heliogen is running hot after an upbeat regulatory decision. The company said the U.S. Patent & Trademark Office awarded it a new patent titled "gas receiver for capturing solar energy." Heliogen unveiled the patent late Tuesday, and shares gained 5.5% following the announcement. The rally continued into the after-market, and Heliogen is still running hot this morning. HLGN is up 34.3% in today's premarket. My Take: HLGN has had a rough run lately, but it has strong support at $0.21 and this catalyst could help it rebound into a new trading range. That's it for today! Thanks for reading, and good luck out there! Best Regards, Chris D. -- Elite Trade Club P.S... Want alerts delivered straight to your cell every morning for free?* Text ELITE to 47121 to sign up now and get our watchlists sent directly to your phone! Or text CLOSE to 47121 to get on the mobile alert list for our Closing Bell Roundup report, featuring the day's top winners and losers. *Standard message/carrier rates may apply. Legal Stuff: Stocks featured in this newsletter are for entertainment purposes only. You should not base any investment decisions on information contained in my newsletter. Stocks featured in this newsletter may be owned by owners/operators of this website which could impact our ability to remain unbiased. Please consult a financial advisor before making any trading decisions. I may earn a small commission from links placed inside of these emails. [Bots click here]( 1969 S. ALAFAYA TRAIL Orlando FL 32828 USA [Unsubscribe]( | [Change Subscriber Options](